KELSEY DENISON: Open Payments
NPI 1457002990 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$923 in 58 payments from 6 companies in 2025. Trend: 2023 $194 · 2024 $614 · 2025 $923
Food & beverage: $923
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $313 |
| ABBVIE INC. | 26 | $263 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $169 |
| Tris Pharma Inc | 6 | $111 |
| Janssen Pharmaceuticals, Inc | 1 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
Products named: COBENFY, VRAYLAR, CAPLYTA, Dyanavel XR, QULIPTA, SPRAVATO, INGREZZA, UBRELVY.
Industry payments across ID — which companies pay providers there.
